Edgewise Therapeutics Inc
(EWTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,485 | 30,264 | 86,097 | 32,957 | 31,807 |
| Marketable Securities | 468,266 | 502,495 | 232,296 | 256,740 | 278,121 |
| TOTAL | $519,441 | $541,427 | $326,997 | $297,921 | $316,997 |
| Non-Current Assets | |||||
| PPE Net | 9,897 | 10,184 | 10,443 | 10,679 | 10,856 |
| Other Non-Current Assets | 2,309 | 2,195 | 2,595 | 2,764 | 2,772 |
| TOTAL | $12,206 | $12,379 | $13,038 | $13,443 | $13,628 |
| Total Assets | $531,647 | $553,806 | $340,035 | $311,364 | $330,625 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,801 | 4,723 | 4,025 | 5,318 | 3,781 |
| TOTAL | $17,176 | $14,600 | $16,771 | $16,338 | $14,400 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,997 | 4,265 | 4,434 | 4,599 | 4,770 |
| TOTAL | $3,997 | $4,265 | $4,434 | $4,599 | $4,770 |
| Total Liabilities | $21,173 | $18,865 | $21,205 | $20,937 | $19,170 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,772 | 93,399 | 93,111 | 63,462 | 63,459 |
| Common Shares | 9 | 9 | 7 | 6 | 6 |
| Retained earnings | -304,785 | -273,288 | -244,763 | -214,620 | -188,907 |
| Other shareholders' equity | -1,054 | -861 | 99 | -424 | -547 |
| TOTAL | $510,474 | $534,941 | $318,830 | $290,427 | $311,455 |
| Total Liabilities And Equity | $531,647 | $553,806 | $340,035 | $311,364 | $330,625 |